Hepatitis C Information - Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved

Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved
Medical News Today - Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company's country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection in

International Approvals: Erbitux, Peg-Intron, Rebetol
Medscape News - Dec. 27, 2005 Switzerland s regulatory authority Swissmedic has approved a new indication for cetuximab injection, allowing its use in combination with radiotherapy for the first-line treatment of locally advanced head and neck cancer. Japan's